Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardiff Oncology (CRDF) Return on Assets (2016 - 2025)

Cardiff Oncology's Return on Assets history spans 14 years, with the latest figure at 0.73% for Q4 2025.

  • For Q4 2025, Return on Assets fell 16.0% year-over-year to 0.73%; the TTM value through Dec 2025 reached 0.73%, down 16.0%, while the annual FY2025 figure was 0.58%, 7.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.73% at Cardiff Oncology, down from 0.72% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.15% in Q1 2021 and bottomed at 0.73% in Q4 2025.
  • The 5-year median for Return on Assets is 0.44% (2023), against an average of 0.43%.
  • The largest annual shift saw Return on Assets surged 120bps in 2021 before it dropped -20bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.2% in 2021, then plummeted by -68bps to 0.33% in 2022, then crashed by -53bps to 0.51% in 2023, then decreased by -11bps to 0.57% in 2024, then dropped by -29bps to 0.73% in 2025.
  • Per Business Quant, the three most recent readings for CRDF's Return on Assets are 0.73% (Q4 2025), 0.72% (Q3 2025), and 0.64% (Q2 2025).